| 000 | 01891 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250516032507.0 | ||
| 264 | 0 | _c20110830 | |
| 008 | 201108s 0 0 fre d | ||
| 022 | _a1953-8022 | ||
| 024 | 7 |
_a10.1016/j.tracli.2011.02.022 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aClément, S | |
| 245 | 0 | 0 |
_a[Techniques of preparation and indications of labile blood products]. _h[electronic resource] |
| 260 |
_bTransfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine _cApr 2011 |
||
| 300 |
_a250-61 p. _bdigital |
||
| 500 | _aPublication Type: English Abstract; Journal Article; Review | ||
| 650 | 0 | 4 |
_aAcute Lung Injury _xetiology |
| 650 | 0 | 4 |
_aBlood Banks _xstandards |
| 650 | 0 | 4 | _aBlood Cells |
| 650 | 0 | 4 |
_aBlood Component Removal _xinstrumentation |
| 650 | 0 | 4 |
_aBlood Component Transfusion _xadverse effects |
| 650 | 0 | 4 |
_aBlood Preservation _xmethods |
| 650 | 0 | 4 |
_aBlood Safety _xstandards |
| 650 | 0 | 4 |
_aBlood-Borne Pathogens _xdrug effects |
| 650 | 0 | 4 |
_aDisease Transmission, Infectious _xprevention & control |
| 650 | 0 | 4 |
_aForms and Records Control _xstandards |
| 650 | 0 | 4 | _aFrance |
| 650 | 0 | 4 |
_aGovernment Agencies _xstandards |
| 650 | 0 | 4 | _aGuidelines as Topic |
| 650 | 0 | 4 |
_aHematologic Diseases _xgenetics |
| 650 | 0 | 4 |
_aHemorrhage _xtherapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfant, Newborn |
| 650 | 0 | 4 |
_aInfant, Newborn, Diseases _xtherapy |
| 650 | 0 | 4 | _aLeukocyte Reduction Procedures |
| 650 | 0 | 4 | _aOrgan Preservation Solutions |
| 650 | 0 | 4 | _aPlasma |
| 650 | 0 | 4 |
_aProduct Labeling _xstandards |
| 650 | 0 | 4 | _aVirus Inactivation |
| 650 | 0 | 4 |
_aBlood Banking _xmethods |
| 773 | 0 |
_tTransfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine _gvol. 18 _gno. 2 _gp. 250-61 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.tracli.2011.02.022 _zAvailable from publisher's website |
| 999 |
_c20741575 _d20741575 |
||